Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 107, 67-80
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore (C-148-000-003-001)
- Ministry of Education - Singapore (R-148-000-193-112)
This publication has 36 references indexed in Scilit:
- CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac HypertrophyPLOS ONE, 2013
- Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial FibrillationClinical Medicine Insights: Cardiology, 2013
- Discovery and Characterization of Novel, Potent, and Selective Cytochrome P450 2J2 InhibitorsDrug Metabolism and Disposition, 2013
- Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 ActivityDrug Metabolism and Disposition, 2012
- Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of AmericaDrug Metabolism and Disposition, 2009
- Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular TissuesDrug Metabolism and Disposition, 2007
- Characterization of Ebastine, Hydroxyebastine, and Carebastine Metabolism by Human Liver Microsomes and Expressed Cytochrome P450 Enzymes: Major Roles for CYP2J2 and CYP3ADrug Metabolism and Disposition, 2006
- The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicityPharmacology & Therapeutics, 1995
- Pharmacokinetics of amiodarone: Implications for drug therapyThe American Journal of Cardiology, 1993